ZELTIQ(R) Aesthetics Appoints Patrick F. Williams as Chief Financial Officer

ZELTIQ(R) Aesthetics Appoints Patrick F. Williams as Chief Financial Officer

Significant Experience in Strategy, Financial Reporting and Investor Relations

PLEASANTON, Calif., Nov. 19, 2012 (GLOBE NEWSWIRE) -- ZELTIQ Aesthetics, Inc.
(Nasdaq:ZLTQ), a medical technology company focused on developing and
commercializing products utilizing its proprietary controlled-cooling
technology platform, today announced that it has further strengthened its
management team with the appointment of Patrick F. Williams as Senior Vice
President and Chief Financial Officer, effective immediately.

Mr. Williams brings to ZELTIQ a strong background in strategic planning,
operational management, financial reporting and investor relations in the high
growth medical technology industry.

Mark Foley, President and Chief Executive Officer, said, "We are extremely
pleased to welcome Patrick as ZELTIQ's Chief Financial Officer. His specific
experience managing finance, strategic planning, and investor relations at a
rapidly growing medical technology company provides him with the valuable
background that we believe will enable him to make immediate and meaningful
contributions at ZELTIQ. Patrick has longstanding relationships with several
members of the medical technology investment community with which we
frequently interact and has proven experience in investor relations best
practices. With the addition of Patrick, we have taken another significant
step toward fully staffing our senior management team with high quality
executives who we believe will help ZELTIQ maintain and expand its leadership
position in the non-surgical fat reduction market."

Patrick Williams, Senior Vice President and Chief Financial Officer, said,
"Joining the ZELTIQ senior management team represents a significant
opportunity. CoolSculpting is clearly an impressive technology, poised to
further expand an already growing non-surgical fat reduction market. I look
forward to working with Mark, the extended management team, and the Board to
drive revenue growth and take advantage of the exciting opportunity ahead of

Mr. Williams joins ZELTIQ with nearly 20 years of financial management
experience.He has spent more than 5 years at NuVasive, Inc. (Nasdaq:NUVA),
most recently as Vice President of Strategy and Investor Relations and
previously as Vice President of Finance and Investor Relations. In his most
recent position, he worked directly with the company's CEO and senior
management team to develop the company's long term growth and operational
strategy while ensuring alignment across the organization. In his prior role,
Mr. Williams was responsible for the day-to-day operations of the finance
department including developing the worldwide budget and forecast, identifying
profitability improvements, and predicting necessary infrastructure changes to
support top-line growth and operating margins. He has had responsibility for
managing all aspects of NuVasive's investor relations efforts as well as
significant government affairs duties. Prior to NuVasive, he was Director of
Financial Planning and Analysis at Callaway Golf, where he managed the
day-to-day operations of the finance department including budgeting and
forecasting, companywide operational analysis and financial reporting. Prior
to Callaway, Mr. Williams held senior finance positions at Kyocera Wireless.
He holds an MBA in Finance and Management from San Diego State University and
a BA in Economics from University of California at San Diego.

About ZELTIQ Aesthetics, Inc.

ZELTIQ® Aesthetics is a medical technology company focused on developing and
commercializing products utilizing its proprietary controlled-cooling
technology platform. ZELTIQ's first commercial product, the CoolSculpting®
System, is designed to selectively reduce stubborn fat bulges that may not
respond to diet or exercise. CoolSculpting is based on the scientific
principle that fat cells are more sensitive to cold than the overlying skin
and surrounding tissues. CoolSculpting utilizes patented technology of
precisely controlled cooling to reduce the temperature of fat cells in the
treated area, which is intended to cause fat cell elimination through a
natural biological process known as apoptosis, without causing scar tissue or
damage to the skin, nerves, or surrounding tissues. ZELTIQ developed
CoolSculpting to safely, noticeably, and measurably reduce the fat layer
within a treated fat bulge without requiring the patient to diet or exercise.

Forward-Looking Statements

The statements in this press release regarding the benefits that ZELTIQ
expects from Mr. Williams joining ZELTIQ are forward-looking statements that
involve known and unknown risks, uncertainties and other factors that are, in
some cases, beyond ZELTIQ's control.Factors that could cause these statements
not to come true include, but are not limited to: less than anticipated growth
in the number of physicians electing to purchase CoolSculpting Systems,
insufficient patient demand for CoolSculpting procedures, product or procedure
announcements by competitors, ZELTIQ's failure to correctly estimate and
control future expenditures, and the failure of ZELTIQ's sales and marketing
plans to increase sales, each of which could cause Mr. William's contributions
to ZELTIQ to not have the benefits that ZELTIQ expects, as well as those other
risks and uncertainties set forth in ZELTIQ's Quarterly Report on Form 10-Q
for the fiscal quarter ended September 30, 2012, filed with the SEC on
November 8, 2012.These forward-looking statements speak only as of the date
of this press release.ZELTIQ expressly disclaims any obligation to update
information contained in these forward-looking statements whether as a result
of new information, future events, or otherwise.

         Patrick Williams
         ZELTIQ, Senior Vice President and CFO

         Nick Laudico / Amy Glynn
         The Ruth Group for ZELTIQ  
         646-536-7030 / 7023

         Shari Gold 
         GOLD PR for ZELTIQ
Press spacebar to pause and continue. Press esc to stop.